Arthri-D3 Name Remains After Testimonials Vanish During NAD Review
This article was originally published in The Tan Sheet
Executive Summary
NAD attorneys agree with CRN that the Arthri-D3 brand, when used in conjunction with testimonials related to relief from arthritis pain, “might convey the misleading message that Arthri-D3 immediately and completely relieves arthritis pain.” However, Arthri-D LLC discontinues the challenged testimonials.
You may also be interested in...
Athlete's Foot Firm Kicks Back On NAD Finding That Brand Is A Fungal Claim
Kramer Laboratories' claims for Fungi-Nail athlete's foot product referred to FDA and FTC after it refuses to comply with NAD's recommendation to modify the name. The firm, which agreed to modify packaging and commercial claims, was warned by FDA about the brand in 2005.
Athlete's Foot Firm Kicks Back On NAD Finding That Brand Is A Fungal Claim
Kramer Laboratories' claims for Fungi-Nail athlete's foot product referred to FDA and FTC after it refuses to comply with NAD's recommendation to modify the name. The firm, which agreed to modify packaging and commercial claims, was warned by FDA about the brand in 2005.
P&G Supports Crest Sensi-Stop Strips Claims In More Than Name Only – NAD
P&G’s Crest Sensi-Stop Strips emerge largely unscathed from a NAD review of claims made in ads and on product packaging. While GSK argued some claims were unsupported, including the product name, NAD determined P&G’s evidence supports claims of immediate relief and protection for up to one month.